Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trialSylvie Bonvalot, Rick L. Haas, Marco Rastrelli et al.|The Lancet Oncology|2020Cited by 482
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statementMatthias Gückenberger, David A. Palma, Claus Belka et al.|Radiotherapy and Oncology|2020Cited by 227
Prognostic Factors in Primary Breast Sarcomas: A Series of Patients With Long-Term Follow-UpLaurent Zelek, Axel Le Cesne, Antonio Llombart‐Cussac et al.|Journal of Clinical Oncology|2003Cited by 219
Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypN0 Stage III-N2 NSCLC after Induction Chemotherapy and ResectionCharlotte Billiet, Dirk De Ruysscher, Stéphanie Peeters et al.|Journal of Thoracic Oncology|2016Cited by 25
Phase II study of concomitant radiotherapy with atezolizumab in oligometastatic soft tissue sarcomas: STEREOSARC trial protocolJennifer Le Guévelou, Juliette Thariat, Colin Debaigt et al.|BMJ Open|2020Cited by 13